Significance of serum free prostate specific antigen in the screening of prostate cancer

Journal of Urology

Volumn 156, Issue 6, 1996, Pages 1964-1968

  Higashihara, Eiji ^a   Nutahara, Kikuo ^a   Kojima, Miho ^a   Okegawa, Takatsugu ^a   Miura, Ichiro ^a   Miyata, Akiomi ^a   Kato, Moriaki ^a   Sugisaki, Hajime ^a   Tomaru, Takeshi ^a  

^a NONE

Author keywords

antigens, neoplasm; diagnosis; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0029861739     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65405-3     Document Type: Article

References (22)

1. Wingo, P. A., Tong, T. and Bolder, S.: Cancer statistics, 1995. Ca, 45: 8, 1995.
2. Jensen, O. M., Esteve, J., Moller, H. and Renard, H.: Cancer in the European community and its member states. Eur. J. Cancer, 26: 1167, 1990.
3. Tominaga, H., Aoki, K., Hanai, A. and Kurihara, N.: Cancer statistics, incidence, death and prognosis - 1993. Shinohara-Shuppan, Tokyo, 1993.
4. Kumamoto, Y., Tsukamoto, T., Umehara, T., Shimazaki, J., Fuse, H., Ohshima, H., Takeuchi, H., Yoshida, O., Okada, K., Saito, Y., Kanatake, H., Harada, M. and Tamiya, T.: Clinical studies on endocrine therapy for prostatic carcinoma (2): prognosis of patients with prostatic carcinoma given endocrine therapy and analyses on causes of death and side effect of endocrine therapy. Acta Urol. Jap., 36: 285, 1990.
5. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
6. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A. and Andriole, G. L.: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
7. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
8. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
9. Labrie, F., Dupont, A., Suburu, R., Cusan, L., Tremblay, M., Gomez, J.-L. and Emond, J.: Serum prostate specific antigen as pre-screening test for prostate cancer. J. Urol., 147: 846, 1992.
10. Oesterling, J. E., Jacobsen, S. J. and Cooner, W. H.: The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J. Urol., 153: 1160, 1995.
11. Oesterling, J. E.: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907, 1991.
12. Christensson, A., Bjork, T., Nilsson, O., Dahlén, U., Matikainen, M., Cockett, A. T. K., Abrahamsson, P.-A. and Lilja, H.: Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150: 100, 1993.
13. Lilja, H., Cockett, A. T. K. and Abrahamsson, P.-A.: Prostate specific antigen predominantly forms a complex with α1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum. Cancer, suppl., 70: 250, 1992.
14. Oesterling, J. E., Jacobsen, S. J., Klee, G. G., Pettersson, K., Piironen, T., Abrahamsson, P.-A., Stenman, U.-H., Dowell, B., Lövgren, T. and Lilja, H.: Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J. Urol., 154: 1090, 1995.
15. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
16. Imai, K., Ichinose, Y., Kubota, Y., Yamanaka, H. and Sato, J.: Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. J. Urol., 154: 1085, 1995.
17. Gustafsson, O., Norming, U., Almgård, L.-E., Fredriksson, A., Gustavsson, G., Harving, B. and Nyman, C. R.: Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men. J. Urol., 148: 1827, 1992.
18. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol., 147: 817, 1992.
19. Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, J. L. and Walsh, P. C.: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. J.A.M.A., 267: 2215, 1992.
20. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. G., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
21. Cookson, M. S., Floyd, M. K., Ball, T. P., Jr., Miller, E. K. and Sarosdy, M. F.: The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J. Urol., 154: 1070, 1995.
22. Mettlin, C., Murphy, G. P., Lee, F., Littrup, P. J., Chesley, A., Babaian, R., Badalament, R., Kane, R. A., Mostofi, F. K. and the investigators of the American Cancer Society - National Prostate Cancer Detection Project: Characteristics of prostate cancer detected in the American Cancer Society - National Prostate Cancer Detection Project. J. Urol., part 2, 152: 1737, 1994.